Recent advances in the research of heterocyclic compounds as antitubercular agents (Q38050102)

27 August 2017

title

Recent advances in the research of heterocyclic compounds as antitubercular agents (English)

1 reference

27 August 2017

Mi Yan

1 reference

27 August 2017

Shutao Ma

series ordinal

1 reference

27 August 2017

publication date

5 October 2012

1 reference

27 August 2017

1 reference

27 August 2017

1 reference

27 August 2017

1 reference

27 August 2017

page(s)

2063-2075

1 reference

Development of new vaccines and diagnostic reagents against tuberculosis

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Synthesis and antimycobacterial activity of novel amino alcohols containing central core of the anti-HIV drugs lopinavir and ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

New drug candidates and therapeutic targets for tuberculosis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Natural products, small molecules, and genetics in tuberculosis drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

New tuberculosis drugs in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

New anti-tuberculosis drugs in clinical trials with novel mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Importance of the thiomorpholine introduction in new pyrrole derivatives as antimycobacterial agents analogues of BM 212.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Biological activities of hydrazone derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Development of new anti-tuberculosis drug candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis, and microbiological evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

New small-molecule synthetic antimycobacterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Ligand-based virtual screening, parallel solution-phase and microwave-assisted synthesis as tools to identify and synthesize new inhibitors of mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Fighting tuberculosis: an old disease with new challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Recent developments in the identification of novel oxazolidinone antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Synthesis of new 4-isopropylthiazole hydrazide analogs and some derived clubbed triazole, oxadiazole ring systems--a novel class of potential antibacterial, antifungal and antitubercular agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Tuberculosis chemotherapy: current drug delivery approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Selective one-pot multicomponent synthesis and anti-tubercular evaluation of 5-(aryl/cyclohexylsulfanyl)-2-alkoxy-4,6-diarylnicotinonitriles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Isonicotinic acid hydrazide derivatives: synthesis, antimicrobial activity, and QSAR studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Inhibition of mycobacterial replication by pyrimidines possessing various C-5 functionalities and related 2'-deoxynucleoside analogues using in vitro and in vivo models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

A virtual screening approach for thymidine monophosphate kinase inhibitors as antitubercular agents based on docking and pharmacophore models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Drug Repositioning in the Treatment of Malaria and TB

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Secondary Metabolites from the Root Wood of Zanthoxylum wutaiense and Their Antitubercular Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Antitubercular Chromones and Flavonoids from Pisonia aculeata

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

In vitro antituberculosis activities of the constituents isolated from Haloxylon salicornicum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Facile synthesis and antibacterial, antitubercular, and anticancer activities of novel 1,4-dihydropyridines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Inhibition of siderophore biosynthesis in Mycobacterium tuberculosis with nucleoside bisubstrate analogues: structure-activity relationships of the nucleobase domain of 5'-O-[N-(salicyl)sulfamoyl]adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Structure-activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((s)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-amino PA-824).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

The effect of 5-substitution on the electrochemical behavior and antitubercular activity of PA-824

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Structure-activity relationships of antitubercular nitroimidazoles. 2. Determinants of aerobic activity and quantitative structure-activity relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Antimycobacterial activity of novel 1,2,4-oxadiazole-pyranopyridine/chromene hybrids generated by chemoselective 1,3-dipolar cycloadditions of nitrile oxides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

A green expedient synthesis of pyridopyrimidine-2-thiones and their antitubercular activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Synthesis and antitubercular evaluation of novel substituted aryl and thiophenyl tethered dihydro-6H-quinolin-5-ones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Synthesis, molecular modeling and bio-evaluation of cycloalkyl fused 2-aminopyrimidines as antitubercular and antidiabetic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Thienopyrimidines as Novel Inhibitors of Mycobacterium tuberclosis: Synthesis and In‐vitro Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Total synthesis of hirsutellone B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Toward the total synthesis of elisapterosin B: a Hg(OTf)2-promoted diastereoselective intramolecular Friedel–Crafts alkylation reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Bioactive metabolites of Diaporthe sp. P133, an endophytic fungus isolated from Pandanus amaryllifolius

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Antituberculosis Cycloartane Triterpenoids from Radermachera boniana

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Synthesis and in vivo biological activity of large-ringed calixarenes against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

Synthesis and antitubercular evaluation of amidoalkyl dibenzofuranols and 1H-benzo[2,3]benzofuro[4,5-e][1,3]oxazin-3(2H)-ones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

7 January 2021

Pharmacophore Optimization and Design of Competitive Inhibitors of Thymidine Monophosphate Kinase Through Molecular Modeling Studies

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

7 January 2021

Dihydro-β-agarofuran sesquiterpenes isolated from Celastrus vulcanicola as potential anti-Mycobacterium tuberculosis multidrug-resistant agents

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

7 January 2021

Design, synthesis and antimycobacterial evaluation of novel 3-substituted-N-aryl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide analogues

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

7 January 2021

Marine natural products

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200339

7 January 2021

Identifiers

DOI

10.1002/CMDC.201200339

1 reference

27 August 2017

1 reference